Furthermore, MAR response was able to assess sensitivity to experimental MM therapies, including the BET inhibitor JQ1 and a peptide-based therapeutic targeting E2F/DP1 interaction, highlighting the potential of functional MAR measurements to assess therapeutic response in research setting. The gene discussed is DNER; the disease is Miyoshi myopathy.